Referências

1 – Nobivac® DHPPi offers protection against infection with CDV and CPV within 7 days of vaccination – Proceedings 46th BSAVA Annual Congress, Birmingham, UK, 3-6 April 2003:p. 559.

2 – An injectable modified live vaccine protects young puppies against challenge with either canine adenovirus-1 or canine adenovirus-2 seven days after a single vaccination – Proceedings 40th Voorjaarsdagen Congress, 27th-29th April 2007, Amsterdam, NL.:p. 193.

3 – Challenge trial of a new
attenuated canine parvovirus vaccine. J. Vet. Int. Med. 1995, 9,197.

4 – Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection – American Journal of Veterinary Research. 1997, 58, 360-363.

5 – Canine parvovirus type 2 protects against virulent challenge with type 2c virus – Veterinary Microbiology. 2008, 128, 48-55.

6 – Nobivac Lepto protects against challenge by L. canicola and L.icterohaemorrhagiae and prevents dogs from becoming renal carriers for at least 13 months – Proceedings 11th ESVIM Congress, Dublin, Ireland, 5-8 September 2001:p. 171.

7 – Duration of immunity in dogs vaccinated against leptospirosis with a bivalent
inactivated vaccine – Veterinary Microbiology, 95(1-2):121-132.

8 – Reduced Risk of Allergic Reactions in Dogs to a New Tetravalent Canine Leptospirosis Vaccine – BVetMed2.

Dots

Proteger é o primeiro cuidado